Updated: March 12, 2026
Zoryve Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

- Common Side Effects of Zoryve Cream (Plaque Psoriasis)
- Common Side Effects of Zoryve Foam (Seborrheic Dermatitis)
- Why Zoryve Causes Systemic Side Effects When Applied to the Skin
- What Zoryve Does NOT Cause (Unlike Topical Steroids)
- Serious Side Effects: What to Watch For
- Special Warning: Zoryve Foam Is Flammable
- When Should You Call Your Doctor?
- Getting Zoryve Safely
Overview
Learn about the common and serious side effects of Zoryve (roflumilast) cream and foam, what to do if they occur, and when to contact your doctor.
Is Zoryve in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Zoryve near you.
Zoryve (roflumilast) cream and foam have one of the most favorable tolerability profiles of any prescription skin medication available in 2026. Unlike topical corticosteroids, they don't cause skin thinning. Unlike some newer topicals, they don't commonly cause folliculitis or contact dermatitis. But like any medication, they do have side effects you should know about.
This guide covers what to expect when using Zoryve, the difference between common and serious side effects, and when to call your doctor.
Common Side Effects of Zoryve Cream (Plaque Psoriasis)
In clinical trials for Zoryve cream 0.3% (plaque psoriasis), the side effects reported in at least 1% of patients included:
Diarrhea (3.1%)
Headache (2.4%)
Insomnia (1.4%)
Nausea (1.2%)
Application site pain (1.0%)
Upper respiratory tract infection (1.0%)
Urinary tract infection (1.0%)
It's important to note that these side effects occurred in a small percentage of patients, and most were mild and temporary. In clinical trials for atopic dermatitis (cream 0.15%), the most common side effects were headache (2.9%), application site pain (1.5%), diarrhea (1.5%), and vomiting (1.5%).
Check live stock now.
Common Side Effects of Zoryve Foam (Seborrheic Dermatitis)
For Zoryve foam 0.3% used for seborrheic dermatitis, the most common adverse reactions (≥1%) were:
Nasopharyngitis/common cold (1.5%)
Nausea (1.3%)
Headache (1.1%)
Why Zoryve Causes Systemic Side Effects When Applied to the Skin
Zoryve is a topical medication, but a small amount of roflumilast does absorb into the bloodstream through the skin. This is why systemic side effects like headache, diarrhea, and nausea can occur — they're the same kinds of side effects seen with oral roflumilast (Daliresp), just at much lower exposure levels because the topical dose is much lower than the oral dose.
Using Zoryve only on the affected areas (not healthy skin) and following the once-daily dosing schedule helps minimize systemic absorption.
What Zoryve Does NOT Cause (Unlike Topical Steroids)
Because Zoryve is not a corticosteroid, it does not cause:
Skin thinning (atrophy)
Stretch marks (striae)
Rebound flares when stopped
Adrenal suppression with long-term use
This is one of the key advantages of Zoryve, particularly for sensitive areas like the face, eyelids, genitals, and skin folds where steroid use is limited.
Serious Side Effects: What to Watch For
Zoryve is not known to cause serious side effects in clinical trials, but rare events can occur with any medication:
Severe allergic reaction: Signs include hives, swelling of the face or throat, difficulty breathing, or a severe rash. Call 911 or go to the emergency room immediately.
Psychiatric symptoms: Oral roflumilast (Daliresp) has been associated with psychiatric effects including depression and suicidal ideation. While this has not been reported with topical Zoryve, inform your doctor if you experience new or worsening mood changes, anxiety, or depression during treatment.
Liver impairment concern: Zoryve is contraindicated in patients with moderate to severe liver impairment (Child-Pugh B or C). If you have liver disease, tell your doctor before starting Zoryve.
Special Warning: Zoryve Foam Is Flammable
This is not a side effect in the clinical sense, but it is a critical safety warning: Zoryve foam contains flammable propellants. Avoid fire, flame, and smoking during and immediately after application. Do not puncture or burn the canister.
Found
Rate
on average
When Should You Call Your Doctor?
Contact your dermatologist if:
You experience severe diarrhea, headache, or nausea that doesn't resolve within a few days
Your skin condition gets worse after starting Zoryve
You develop signs of an allergic reaction: rash, itching, swelling, or difficulty breathing
You notice new or unusual mood changes, depression, or anxiety
Getting Zoryve Safely
Understanding side effects is just one piece of safely using Zoryve. Also be aware of drug interactions — see our full guide on Zoryve drug interactions and what to avoid. If you're having trouble finding Zoryve at a pharmacy, medfinder.com can call pharmacies near you to find where it's available.
Frequently Asked Questions
In clinical trials for Zoryve cream 0.3% (plaque psoriasis), the most common side effects (≥1%) were diarrhea (3.1%), headache (2.4%), insomnia (1.4%), nausea (1.2%), application site pain (1.0%), upper respiratory tract infection (1.0%), and urinary tract infection (1.0%). Most were mild and temporary.
A small amount of roflumilast from Zoryve is absorbed through the skin into the bloodstream. At these low topical doses, systemic effects like headache and diarrhea can occur in some patients — the same types of effects seen with oral roflumilast (Daliresp), just at much lower frequency and severity.
No. Zoryve is not a corticosteroid and does not cause skin thinning (atrophy), stretch marks, or adrenal suppression. This makes it suitable for long-term use anywhere on the body, including sensitive areas like the face, eyelids, genitals, and skin folds where topical steroid use is typically limited.
Yes — Zoryve foam is flammable. The FDA labeling explicitly warns patients to avoid fire, flame, and smoking during and immediately after applying Zoryve foam. Do not puncture or burn the canister. This is a safety hazard, not a side effect, but it's a critical point for safe use.
Oral roflumilast (Daliresp) has been associated with psychiatric effects including depression and suicidal ideation. These effects have not been reported in clinical trials with topical Zoryve, likely because systemic absorption is much lower. However, inform your doctor if you experience new or worsening mood changes, anxiety, or depression while using Zoryve.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Zoryve also looked for:
More about Zoryve
38,004 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





